Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: Involvement of peripheral benzodiazepine receptors

Brain Research

Volumn 904, Issue 1, 2001, Pages 149-152

  Raghavendra, V ^a   Naidu, P S ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Central peripheral benzodiazepine receptors; Dyskinesia; Melatonin; Reserpine; Vacuous chewing movements (VCMs)

Indexed keywords

BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; FLUMAZENIL; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PRAZOSIN; RECEPTOR BLOCKING AGENT; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; MASTICATION; NONHUMAN; PRIORITY JOURNAL; RAT; TARDIVE DYSKINESIA;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DYSKINESIA, DRUG-INDUCED; FLUMAZENIL; GABA MODULATORS; GAMMA-AMINOBUTYRIC ACID; ISOQUINOLINES; MALE; MASTICATION; MELATONIN; NEOSTRIATUM; PRAZOSIN; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, GABA-A; RECEPTORS, MELATONIN; RESERPINE; TRYPTAMINES;

EID: 0035875763     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02455-6     Document Type: Article

References (20)

1. Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?
2. Melatonin action in the midbrain can regulate forebrain dopamine function both behaviorally and biochemically
3. Melatonin effects on brain and behaviour
4. Pathogenesis, prevention, and treatment of neuroleptic-induced movement disorders
5. Neurobiological substrates of tardive dyskinesia: The GABA hypothesis
6. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration
7. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis
8. The nullification by diazepam of haloperidol-induced increase in the level of striatal dopamine but not in the activity of glutamic acid decarboxylase
9. Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats
10. Current concepts in the molecular diversity and pharmacology of dopamine receptors
11. Dose dependent differences in the development of reserpine-induced oral dyskinesia in rats: Support for a model of tardive dyskinesia
12. Reversal of morphine tolerance and dependence by melatonin: Possible role of central and peripheral benzodiazepine receptors
13. Antidepressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation
14. Increased incidence and severity of neuroleptic-induced movement disorder in pinealectomized rats
15. Tardive dyskinesia associated with depression in a bipolar patient: Possible role of melatonin
16. Sustained improvement in tardive dyskinesia with diazepam: Indirect evidence for cortico-limbic involvement
17. Central-type benzodiazepine receptors mediate the antidopaminergic effect of clonazepam and melatonin in 6-hydroxydopamine lesioned rats: Involvement of a gabaergic mechanism
18. Mechanisms underlying the antidopaminergic effect of clonazepam and melatonin in striatum
19. Clonazepam treatment of tardive dyskinesia: A practical GABA mimetic study
20. Preclinical evaluation of the reinforcing and discriminative stimulus effects of agomelatine (S-20098), a melatonin agonist